Purchases and Sales Made in Q3 2023 in Essa Pharma Inc. (EPIX)
This table provides information about the institutional ownership of Essa Pharma Inc. (EPIX) during Q3 2023. The information is specifically focused on institutions that hold shares of ESSA Pharma Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
313K+ 8.08% |
$828K - $1.03M
|
4.18M
$7.65M
|
|
Nov 13, 2023
Q3 2023
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
BUY
|
- |
123K+ 52.35% |
$325K - $405K
|
357K
$652K
|
|
Nov 14, 2023
Q3 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
BUY
|
- |
85K+ 2.02% |
$225K - $281K
|
4.29M
$7.85M
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
46.2K+ 93.33% |
$123K - $153K
|
95.8K
$175K
|
|
Nov 14, 2023
Q3 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
13.7K+ 2.06% |
$36.3K - $45.3K
|
677K
$1.24M
|
|
Nov 09, 2023
Q3 2023
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
10.6K+ 33.89% |
$28.1K - $35.1K
|
41.9K
$76.6K
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
6.78K+ 129.67% |
$18K - $22.4K
|
12K
$22K
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
5.42K+ 239.54% |
$14.4K - $17.9K
|
7.68K
$14K
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
BUY
|
- |
1.29KNew |
$3.41K - $4.26K
|
1.29K
$2.36K
|
|
Nov 14, 2023
Q3 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
723+ 93.29% |
$1.92K - $2.39K
|
1.5K
$2.74K
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-265- 61.63% |
$702 - $877
|
165
$302
|
|
Nov 01, 2023
Q3 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-2.02K- 35.51% |
$5.35K - $6.69K
|
3.67K
$6.71K
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-5.41K- 49.69% |
$14.3K - $17.9K
|
5.48K
$10K
|
|
Nov 14, 2023
Q3 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-5.7K- 0.14% |
$15.1K - $18.9K
|
4.2M
$7.68M
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-6.76K- 30.79% |
$17.9K - $22.4K
|
15.2K
$27.8K
|
|
Nov 13, 2023
Q3 2023
|
Cibc World Market Inc.
Toronto, A6 |
SELL
|
- |
-11.5K- 7.16% |
$30.5K - $38.1K
|
149K
$273K
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-14.4K- 32.93% |
$38.3K - $47.8K
|
29.4K
$53.9K
|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-25.4K- 30.86% |
$67.3K - $84.1K
|
56.9K
$104K
|
|
May 16, 2024
Q3 2023
|
Connective Capital Management, LLC
Palo Alto, CA |
SELL
|
- |
-58.1K- 40.74% |
$154K - $192K
|
84.6K
$155K
|
|
Nov 14, 2023
Q3 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-79.6K- 8.63% |
$211K - $263K
|
842K
$1.54M
|
|
Nov 09, 2023
Q3 2023
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-123K- 34.36% |
$325K - $405K
|
234K
$428K
|